Abingworth Attracts $375M For Its New Bioventures Fund
This article was originally published in Start Up
Executive Summary
The committed capital is nearly half what the 40-year-old firm raised from its previous vehicle and its sidecar in 2007–2008, but it's a huge sum compared with what most life science VCs can drum up these days.